BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37038225)

  • 1. The prognostic value of monocyte-to-lymphocyte ratio in peritoneal dialysis patients.
    Yang Y; Xu Y; Lu P; Zhou H; Yang M; Xiang L
    Eur J Med Res; 2023 Apr; 28(1):152. PubMed ID: 37038225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte/Lymphocyte Ratio and Cardiovascular Disease Mortality in Peritoneal Dialysis Patients.
    Wen Y; Zhan X; Wang N; Peng F; Feng X; Wu X
    Mediators Inflamm; 2020; 2020():9852507. PubMed ID: 32214908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling Nutritional Status (CONUT) score as immune-nutritional predictor of outcomes in patients undergoing peritoneal dialysis.
    Zhou H; Chao W; Cui L; Li M; Zou Y; Yang M
    Clin Nutr; 2020 Aug; 39(8):2564-2570. PubMed ID: 31787366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The advanced lung cancer inflammation index is associated with mortality in peritoneal dialysis patients.
    Ren Z; Wu J; Wu S; Zhang M; Shen S
    BMC Nephrol; 2024 Jun; 25(1):208. PubMed ID: 38918730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Monocyte/Lymphocyte Ratio as Risk Marker for Cardiovascular Events and Infectious Disease Hospitalization in Dialysis Patients.
    Muto R; Kato S; Lindholm B; Qureshi AR; Ishimoto T; Kosugi T; Maruyama S
    Blood Purif; 2022; 51(9):747-755. PubMed ID: 34814140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: A prospective cohort study.
    Xiang F; Chen R; Cao X; Shen B; Liu Z; Tan X; Ding X; Zou J
    Hemodial Int; 2018 Jan; 22(1):82-92. PubMed ID: 28403540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: a retrospective cohort study.
    Fan Z; Li Y; Ji H; Jian X
    BMJ Open; 2018 Oct; 8(10):e023459. PubMed ID: 30341133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the systemic inflammation response index (SIRI) as a novel prognostic marker for patients on peritoneal dialysis.
    Li J; Li Y; Zou Y; Chen Y; He L; Wang Y; Zhou J; Xiao F; Niu H; Lu L
    Ren Fail; 2022 Dec; 44(1):1227-1235. PubMed ID: 35848372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between monocyte-lymphocyte ratio and all-cause and cardiovascular mortality in patients with chronic kidney diseases: A data analysis from national health and nutrition examination survey (NHANES) 2003-2010.
    Liu W; Weng S; Cao C; Yi Y; Wu Y; Peng D
    Ren Fail; 2024 Dec; 46(1):2352126. PubMed ID: 38832474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of the combination of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio on mortality in patients on maintenance hemodialysis.
    Liao J; Wei D; Sun C; Yang Y; Wei Y; Liu X
    BMC Nephrol; 2022 Dec; 23(1):393. PubMed ID: 36482367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between aminotransferase/alanine aminotransferase ratio and cardiovascular disease mortality in patients on peritoneal dialysis: a multi-center retrospective study.
    Feng X; Wen Y; Peng FF; Wang N; Zhan X; Wu X
    BMC Nephrol; 2020 Jun; 21(1):209. PubMed ID: 32487078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.
    Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X
    BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The systemic inflammation indexes predict all-cause mortality in peritoneal dialysis patients.
    Yang Y; Xu Y; Liu S; Lu P; Zhou H; Yang M
    Ren Fail; 2023 Dec; 45(1):2160348. PubMed ID: 37417210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of objective nutritional indexes as predictors of worse outcomes in peritoneal dialysis patients.
    Yang Y; Zhou H; Zhang P; Chao W; Zou Y; Yang M
    Nutrition; 2020; 79-80():110963. PubMed ID: 33011471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte-to-lymphocyte ratio predicts mortality and cardiovascular mortality in the general population.
    Hua Y; Sun JY; Lou YX; Sun W; Kong XQ
    Int J Cardiol; 2023 May; 379():118-126. PubMed ID: 36905945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monocyte/lymphocyte ratio as a predictor of 30-day mortality and adverse events in critically ill patients: analysis of the MIMIC-III database].
    Li Y; Liu Y; Zhou C; Zhang Z; Zuo X; Li J; Cao Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 May; 33(5):582-586. PubMed ID: 34112297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of inflammation-based prognostic scores on outcome in patients undergoing continuous ambulatory peritoneal dialysis.
    Cai L; Yu J; Yu J; Peng Y; Ullah H; Yi C; Lin J; Yang X; Yu X
    BMC Nephrol; 2018 Oct; 19(1):297. PubMed ID: 30367618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Monocyte Count and Monocyte/Lymphocyte Ratio with the Risk of Cardiovascular Outcomes in Patients with CKD.
    Oh ES; You Z; Nowak KL; Jovanovich AJ
    Kidney360; 2022 Apr; 3(4):657-665. PubMed ID: 35721602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio as a prognostic factor in non-endometrioid endometrial cancer.
    Song H; Jeong MJ; Cha J; Lee JS; Yoo JG; Song MJ; Kim JH; Lee SJ; Lee HN; Yoon JH; Park DC; Kim SI
    Int J Med Sci; 2021; 18(16):3712-3717. PubMed ID: 34790044
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutrophil Percentage-to-Albumin Ratio and Risk of Mortality in Patients on Peritoneal Dialysis.
    Yu Y; Zhong Z; Yang W; Yu J; Li J; Guo X; Chen J; Mao H; Li Z
    J Inflamm Res; 2023; 16():6271-6281. PubMed ID: 38146321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.